Liver transplantation from non-heart-beating donors: Current status and future prospects

Liver Transplantation

Volumn 10, Issue 10, 2004, Pages 1223-1232

  Reddy, Srikanth ^a   Zilvetti, Miguel ^a   Brockmann, Jens ^a   McLaren, Andrew ^a   Friend, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 9 DEOXY 9ALPHA,6 NITRILO 15 (4 PROPYLCYCLOHEXYL) 16,17,18,19,20 PENTANORPROSTAGLANDIN F1 ALPHA METHYL ESTER; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; CELSIOR; CLODRONIC ACID; GLUCAGON; HEPARIN; LAZAROID; MILRINONE; NAFAMSTAT MESILATE; OXYGEN; PENTOXIFYLLINE; PHENTOLAMINE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; STREPTOKINASE; TACROLIMUS; TAK 044; TAURODEOXYCHOLIC ACID; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ARTERY THROMBOSIS; BILE DUCT OBSTRUCTION; BRAIN DEATH; CADAVER DONOR; CHOLESTASIS; CHRONIC DISEASE; CRYOPRESERVATION; DEATH; DISEASE MODEL; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HEART ARREST; HEPATIC ARTERY; HUMAN; INFORMED CONSENT; ISCHEMIA; KIDNEY FAILURE; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL ETHICS; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

CADAVER; CLINICAL TRIALS; HUMANS; LIVER FAILURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 6444241320     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20268     Document Type: Review

References (70)

1. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995;27:2893-2894.
2. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc 1995;27:2965.
3. D'Alessandro AM, Hoffmann RM, Knechtle SJ, Odorico JS, Becker YT, Musat A, et al. Liver transplantation from controlled non-heart-beating donors. Surgery 2000;128:579-588.
4. Fukumori T, Kato T, Levi D, Olson L, Nishida S, Ganz S, et al. Use of older controlled non-heart-beating donors for liver transplantation. Transplantation 2003;75:1171-1174.
5. Abt P, Crawford M, Desai N, Markmann J, OlthoffK, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003;75:1659-1663.
6. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-978.
7. Bronk SF, Gores GJ. Efflux of protons from acidic vesicles contributes to cytosolic acidification of hepatocytes during ATP depletion. Hepatology 1991;14(4 Pt 1):626-633.
8. Carini R, Autelli R, Bellomo G, Albano E. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res 1999;248:280-293.
9. Gasbarrini A, Borle AB, Farghali H, Bender C, Francavilla A, Van Thiel D. Effect of anoxia on intracellular ATP, Na+i, Ca2 + i, Mg2+i, and cytotoxicity in rat hepatocytes. J Biol Chem 1992;267:6654-6663.
10. Schroeder RA, Kuo PC. Local consequences of reperfusion following transplantation. In: Grace PA, Mathie RT, eds. Ischemia-reperfusion injury. London: Blackwell Science, 1999:113-122.
11. Goode HF, Webster NR, Howdle PD, Leek JP, Lodge JP, Sadek SA, Walker BE. Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology 1994;19:354-359.
12. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia / reperfusion injury. Hepatology 2000; 32:169-173.
13. Lehmann TG, Koeppel TA, Kirschfink M, Gebhard MM, Herfarth C, Otto G, Post S. Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. Transplantation 1998;66:717-722.
14. Scoazec JY, Borghi-Scoazec G, Durand F, Bernuau J, Pham BN, Belghiti J, et al. Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance. Gastroenterology 1997;112:908-918.
15. Kalayoglu M, Sollinger HW, Stratta RJ, D'Alessandro AM, Hoffmann RM, Pirsch JD, Belzer FO. Extended preservation of the liver for clinical transplantation. Lancet 1988;1(8586):617-619.
16. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 1992;16:454-461.
17. van Der Hoeven JA, Ter Horst GJ, Molema G, de Vos P, Girbes AR, Postema F, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000;232:804-813.
18. Van der Hoeven JA, Lindell S, van Schilfgaarde R, Molema G, Ter Horst GJ, Southard JH, Ploeg RJ. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation 2001;72:1632-1636.
19. Compagnon P, Wang H, Lindell SL, Ametani MS, Mangino MJ, D'Alessandro AM, Southard JH. Brain death does not affect hepatic allograft function and survival after orthotopic transplantation in a canine model. Transplantation 2002;73:1218-1227.
20. Jassem W, Koo DD, Muiesan P, Cerundolo L, Rela M, Fuggle SV, Heaton ND. Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation. Transplantation 2003;75:1386-1390.
21. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998;338:221-225.
22. Nicholson ML, Metcalfe MS, White SA, Waller JR, Doughman TM, Horsburgh T, Feehally J, et al. A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int 2000;58:2585-2591.
23. Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002;347:248-255.
24. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995;59:197-203.
25. Balupuri S, Buckley P, Snowden C, Mustafa M, Sen B, Griffiths P, et al. The trouble with kidneys derived from the non heart-beating donor: a single center 10-year experience. Transplantation 2000;69:842-846.
26. van der Vliet JA, Kievit JK, Hene RJ, Hilbrands LB, Kootstra G. Preservation of non-heart-beating donor kidneys: a clinical prospective randomised case-control study of machine perfusion versus cold storage. Transplant Proc 2001;33:847.
27. Non-heart-beating organ transplantation: medical and ethical issues in procurement (1997). Institute of Medicine, National Academy Press. Available online at http://books.nap.edu/books/ 0309064244/html/index.html.
28. Non-heart-beating organ transplantation: practice and protocols (2000). Institute of Medicine, National Academy Press. Available online at http://www.nap.edu/books/0309066417/html.
29. Youngner SJ, Arnold RM. Ethical, psychosocial, and public policy implications of procuring organs from non-heart-beating cadaver donors. JAMA 1993;269:2769- 2774.
30. Obermann K, Nagel E, Pichlmayr R. Ethical considerations in procuring organs from non-heart-beating donors after sudden cardiac death. Transplant Proc 1995;27:2924-2925.
31. Olson L, Castro VL, Ciancio G, Burke G, Nery J, Cravero LB, et al. Twelve years' experience with non-heart-beating cadaveric donors. J Transpl Coord 1996;6:196-199.
32. Reich DJ, Munoz SJ, Rothstein KD, Nathan HM, Edwards JM, Hasz RD, Manzarbeitia CY. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation 2000;70:1159-1166.
33. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004;239: 87-92.
34. Olson L, Davi R, Barnhart J, Burke G, Ciancio G, Miller J, Tzakis A. Non-heart-beating cadaver donor hepatectomy 'the operative procedure'. Clin Transplant 1999;13(1 Pt 2):98-103.
35. Garcia-Rinaldi R, Lefrak EA, Defore WW, Feldman L, Noon GP, Jachimczyk JA, DeBakey ME. In situ preservation of cadaver kidneys for transplantation: laboratory observations and clinical application. Ann Surg 1975;182:576-584.
36. Tojimbara T, Wicomb WN, Garcia-Kennedy R, Burns W, Hayashi M, Collins G, Esquivel CO. Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function. Liver Transpl Surg 1997;3:39-45.
37. Valero R, Cabrer C, Oppenheimer F, Trias E, Sanchez-Ibanez J, De Cabo FM, et al. Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int 2000;13:303-310.
38. Alvarez J, dei B arrio R, Arias J, Ruiz F, Iglesias J, de Elias R, et al. Non-heart-beating donors from the streets: an increasing donor pool source. Transplantation 2000;70:314-317.
39. Vilca Melendez H, Rela M, Murphy G, Heaton N. Assessment of graft function before liver transplantation: quest for the lost ark? Transplantation 2O00;70:560-565.
40. Otero A, Gomez-Gutierrez M, Suarez F, Arnal F, Fernandez-Garcia A, Aguirrezabalaga J, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 2003;76:1068-1073.
41. St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet 2002;359:604-613.
42. Garcia-Valdecasas JC, Tabet J, Valero R, Deulofeu R, Taura P, Rull R, et al. Evaluation of ischemic injury during liver procurement from non-heart-beating donors. Eur Surg Res 1999;31: 447-456.
43. Valero R, Garcia-Valdecasas JC, Net M, Beltran J, Ordi J, Gonzalez FX, et al. L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart-beating donor pigs. Transplantation 2000;70:730-737.
44. Schon MR, Kollmar O, Wolf S, Schrem H, Matthes M, Akkoc N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001;233:114-123.
45. St Peter SD, Imber CJ, Lopez 1, Hughes D, Friend PJ. Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg 2002;89:609-616.
46. Schon MR, Hunt CJ, Pegg DE, Wight DG. The possibility of resuscitating livers after warm ischemic injury. Transplantation 1993;56:24-31.
47. Lee CY, Zhang JX, Jones JW Jr, Southard JH, Clemens MG. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation 2002;74:944-951.
48. Lee CY, Jain S, Duncan HM, Zhang JX, Jones JW, Jr., Southard JH, Clemens MG. Survival transplantation of preserved non-heart-beating donor rat livers: preservation by hypothermic machine perfusion. Transplantation 2003;76:1432-1436.
49. Saad S, Minor T, Kotting M, Fu ZX, Hagn U, Paul A, Nagelschmidt M. Extension of ischemic tolerance of porcine livers by cold preservation including postconditioning with gaseous oxygen. Transplantation 2001;71:498-502.
50. Lauschke H, Kotting M, Akbar S, Minor T. Use of taurine as antioxidant in resuscitating livers from non-heart-beating donors by gaseous oxygen persufflation. J Invest Surg 2003;16:7-11.
51. Minor T, Isselhard W. Synthesis of high energy phosphates during cold ischemic rat liver preservation with gaseous oxygen insufflation. Transplantation 1996;61:20-22.
52. Yamauchi J, Richter S, Vollmar B, Menger MD, Minor T. Microcirculatory perfusion pattern during harvest of livers from non-heart-beating donors: beneficial effect of warm preflush with streptokinase. Transplant Proc 2000;32:21-22.
53. Minor T, Hachenberg A, Tolba R, Pauleit D, Akbar S. Fibrinolytic preflush upon liver retrieval from non-heart beating donors to enhance postpreservation viability and energetic recovery upon reperfusion. Transplantation 2001;71:1792-1796.
54. Gok MA, Shenton BK, Buckley PE, Peaston R, Cornell C, Leung E, et al. Use of thrombolytic streptokinase as a preflush in the NHBD procurement. Transplant Proc 2003;35:769-770.
55. Ohwada S, Sunose Y, Aiba M, Tsutsumi H, Iwazaki S, Totsuka O, et al. Advantages of Celsior solution in graft preservation from non-heart-beating donors in a canine liver transplantation model. J Surg Res 2002;102:71-76.
56. Minor T, Akbar S. Enhancement of endogenous cyclic AMP signal: a new approach to allow for cold preservation of rat livers from non-heart-beating donors? Transplantation 1998;66:990-994.
57. Manika A, Trinh T, Lagace G, Dugas MA, Proulx F, Lepage G, et al. N-acetylcysteine in pig liver transplantation from non-heart-beating donors. Transplantation 1999;68:327-330.
58. Gu M, Takada Y, Fukunaga K, Ishiguro S, Taniguchi H, Seino K, et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. Transplantation 2000;70:1021-1025.
59. Scarpa M, Corazza A, Vianello F, Rigo A, Furian L, Baldan N, Rigotti P. Deuterium nuclear magnetic resonance for evaluating the metabolic status of livers subjected to warm ischemia. Transplantation 2001;71:1515-1517.
60. Net M, Valero R, Almenara R, Rull R, Gonzales FJ, Taura P, et al. Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation 2001;71: 1232-1237.
61. Valero R, Garcia-Valdecasas JC, Tabet J, Taura P, Rull R, Beltran J, et al. Hepatic blood flow and oxygen extraction ratio during normothermic recirculation and total body cooling as viability predictors in non-heart-beating donor pigs. Transplantation 1998;66:170-176.
62. Nagayama M, Katsuramaki T, Kimura H, Isobe M, Meguro M, Matsuno T, et al. Prediction of graft viability from non-heart-beating donor pigs using hepatic microdialysate hypoxanthine levels. J Surg Res 2002;107:210-218.
63. Richter S, Yamauchi J, Minor T, Menger MD, Vollmar B. Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non-heart-beating donor rat-model. Transpl Int 2000;13:225-229.
64. Ikegami T, Nishizaki T, Hiroshige S, Ohta R, Yanaga K, Sugimachi K. Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function. Br J Surg 2001;13:88:59-64.
65. Tsukamoto S, Ohkohchi N, Fukumori T, Orii T, Asakura T, Takayama J, et al. Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart-beating donors. Transplantation 1999; 67:1396-1403.
66. Xu HS, Stevenson WC, Pruett TL, Jones RS. Donor lazaroid pretreatment improves viability of livers harvested from non-heart-beating rats. Am J Surg 1996;171:113-116; discussion 116-117.
67. Kim YI, Kawano K, Goto S, Yoshida T, Kamada N. Efficacy of prostacyclin analogue (OP-2507) in viable hepatic grafts from pigs with non-beating hearts. Transpl Int 1994;7(Suppl 1):S199-S203.
68. Takada Y, Taniguchi H, Fukunaga K, Yuzawa K, Otsuka M, Todoroki T, et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. Surgery 1998;123:692-698.
69. Ejiri S, Eguchi Y, Kishida A, Ishigami F, Kurumi Y, Tani T, Kodama M. Cellular distribution of thrombomodulin as an early marker for warm ischemic liver injury in porcine liver transplantation: protective effect of prostaglandin 12 analogue and tauroursodeoxycholic acid. Transplantation 2001;71:721-726.
70. Astarcioglu H, Karademir S, Unek T, Ozer E, Menekay S, Coker A, Astarcioglu I. Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats. Transplantation 2000;69: 93-98.